Cargando…
Silibinin attenuates radiation-induced intestinal fibrosis and reverses epithelial-to-mesenchymal transition
Radiotherapy is a common treatment for cancer patients, but its use is often restricted by the tolerance of normal tissue. As cancer patients live longer, delayed radiation effects on normal tissue have become a concern. Radiation-induced enteropathy, including inflammatory bowel disease and fibrosi...
Autores principales: | Kim, Joong Sun, Han, Na-Kyung, Kim, Sung-Ho, Lee, Hae-June |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642486/ https://www.ncbi.nlm.nih.gov/pubmed/29050211 http://dx.doi.org/10.18632/oncotarget.20624 |
Ejemplares similares
-
Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition
por: Kyung, Sun Young, et al.
Publicado: (2018) -
Targeting Src attenuates peritoneal fibrosis and inhibits the epithelial to mesenchymal transition
por: Wang, Jun, et al.
Publicado: (2017) -
The ameliorative effect of silibinin against radiation-induced lung injury: protection of normal tissue without decreasing therapeutic efficacy in lung cancer
por: Son, Yeonghoon, et al.
Publicado: (2015) -
Radiation driven epithelial-mesenchymal transition is mediated by Notch signaling in breast cancer
por: Kim, Rae-Kwon, et al.
Publicado: (2016) -
Silibinin inhibits the migration, invasion and epithelial-mesenchymal transition of prostate cancer by activating the autophagic degradation of YAP
por: Dan, Weichao, et al.
Publicado: (2022)